Spencer D. Brown's most recent trade in PDS Biotechnology Corporation was a trade of 150,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 28, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PDS Biotechnology Corporation | Spencer D. Brown | Senior VP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) | |
| PDS Biotechnology Corporation | Spencer D. Brown | Senior VP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 56,000 | 56,000 | - | - | Employee Stock Option (Right to Buy) | |
| PDS Biotechnology Corporation | Spencer D. Brown | Senior VP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 20,400 | 20,400 | - | - | Employee Stock Option (Right to Buy) | |
| PDS Biotechnology Corporation | Spencer D. Brown | Senior VP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) |